Oral Tissue & Cell Banking Service

About Cellivia

Cellivia is an early-stage biotech firm positioned at the intersection of biotechnology, medicine, and robotics, focusing on regenerative medicine. Its core business is banking oral tissues and cells, which are rich sources of mesenchymal stem cells (MSCs) with high regenerative potential, for future therapeutic use. The company targets a B2B2C model, partnering with dental clinics to collect materials and offering individuals a long-term health security service. While currently a service-based biobank, Cellivia is engaged in R&D to develop advanced therapy medicinal products (ATMPs) from its banked cells.

Therapeutic Areas